BRK, Active

  • Catalog number
    7708-5
  • Price
    Please ask
  • Size
    5 ug
  • Synonyms
    BRK, PTK6 protein tyrosine kinase 6
  • Alternative_names
    BRK, PTK6 protein tyrosine kinase 6
  • Description
    An intracellular signal transducer in epithelial tissues.
  • Recombinant
    Yes
  • Source
    Baculovirus (Sf9 insect cells)
  • Purity by SDS PAGE
    ≥95%
  • Assay
    SDS-PAGE
  • Activity Specifications test method
    133 nmol phosphate incorporated into Poly (Glu-Tyr) per minute per mg protein at 30°C for 15 minutes using a final concentration of 50 µM ATP and total of 0.83 uCi/µl P-32.
  • Molecular Weight
    ~80.0 kDa
  • Storage Temp
    -80°C
  • Shipping
    Dry ice
  • Shelf Life
    12 months
  • Concentration
    5µg/50 µl
  • Appearance
    Liquid
  • Physical form description
    Recombinant protein in storage buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA, 0.1 mM PMSF, 25% glycerol).
  • Background Information
    BRK is another member of the non-receptor tyrosine kinases (PTKs) that contains an amino terminal SH3 and SH2 domains as well as the catalytic domain (1). Although BRK shows strongest sequence similarity to members of the Src family, there are several key structural and regulatory differences that place it on its own amongst non-receptor PTKs. The genomic structure of BRK consists of 8 exons, whose boundaries are distinct from other non-receptor PTK family members (2). Alternate splicing of the primary BRK transcript generates a distinct mRNA which encodes a truncated protein consisting of an SH3 domain and a novel C-terminal proline rich sequence. Brk transcript is expressed in the human breast tumor cell line and expression of a tumor derived Brk cDNA in mouse embryonic fibroblasts and human mammary epithelial cells supports anchorage independent growth, and in the latter potentiates the mitogenic response to epidermal growth factor. Brk expression is low or undetectable in normal mammary tissue and benign lesions. However, approximately two-thirds of breast tumors express appreciable levels and 27% of tumors over express BRK by fivefold or more (up to 43x). This expression pattern is mirrored in comparison of cell lines derived either from normal mammary epithelial cells or from carcinomas (3).
  • Gene target
    BRK   Active  
  • Gene symbol
    PTK6, BMPR2
  • Short name
    BRK, Active
  • Alternative name
    BRK, functionnal
Gene info
  • Identity
  • Gene
  • Long gene name
    protein tyrosine kinase 6
  • Synonyms gene name
    • PTK6 protein tyrosine kinase 6
  • Synonyms
  • GenBank acession
  • Locus
  • Discovery year
    1992-10-02
  • Entrez gene record
  • Pubmed identfication
  • Classification
    • PTK6 family tyrosine kinases
    • SH2 domain containing
  • VEGA ID
Gene info
  • Identity
  • Gene
  • Long gene name
    bone morphogenetic protein receptor type 2
  • Synonyms gene
  • Synonyms gene name
    • primary pulmonary hypertension 1
    • bone morphogenetic protein receptor, type II (serine/threonine kinase)
    • bone morphogenetic protein receptor type II
  • Synonyms
  • GenBank acession
  • Locus
  • Discovery year
    1997-03-19
  • Entrez gene record
    659
  • Pubmed identfication
  • RefSeq identity
  • Classification
    • Type 2 receptor serine/threonine kinases
  • VEGA ID
  • Locus Specific Databases
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee